Integrated Research share price rises on record FY19 result

The Integrated Research Ltd (ASX: IRI) share price has jumped more than 5% in early trade after the software company reported a record full-year result

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Integrated Research Limited (ASX: IRI) share price has jumped in early trade after the software company reported a record full-year result prior to market open.

a woman

What did Integrated Research announce?

For the year ended 30 June 2019 (FY19), Integrated Research announced that it had passed key milestones in hitting $100 million in revenue and $20 million in profit for the first time.

The Aussie performance management software group increased net profit after tax (NPAT) by 14% on the prior corresponding period (pcp) to $21.9 million, at the top end of its July 2019 guidance range.

The strong profit result was made possible by a 19% increase in new licence sales throughout the year, which saw revenue surge 11% on pcp to $100.8 million.

The biggest contributor to revenue was the group's Unified Communications and Contact Centre segment, which comprised roughly half of all earnings despite a 7% decrease on pcp.

Payments revenue surged 92%, albeit off a low base, to $16 million for the year largely thanks to a combination of new and renewal business, while the company's Infrastructure segments increased by 28% to $26.3 million.

However, management is not resting on its laurels following the strong result, with gross spending on research and development maintained at 19% of revenue while Integrated Research's earnings before interest, tax, depreciation and amortisation (EBITDA) remains at 40%.

Positively for shareholders, Integrated Research's net profit after tax (NPAT) margin edged higher to 22% (versus 21% in pcp) as NPAT surged 12% higher for the year.

On the dividend side, Integrated Research directors declared a fully franked, interim dividend of 3.75 cents per share (cps), which takes the company's full-year dividend to 7.25 cps (versus 6.5 cps in pcp).

Foolish takeaway

All in all I think this morning's result was a positive one for Integrated Research and its shareholders, underscored by the strong profit numbers and margins.

Investors look like they tend to agree, with the Integrated Research share price trading more than 5% higher at one point in morning trade and currently trading 3.86% higher at time of writing. Overall, the shares have climbed nearly 60% higher since the start of the year.

Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »